FDA Approved Trikafta: It Has the Potential to Benefit 90 Percent of Cystic Fibrosis Patients
A recent article in the Washington Post tells the story of a newly-approved cystic fibrosis drug that represents thirty years of scientific work and dedication. The defective gene that causes cystic…